Catalyst Wire Dossier Catalyst Wire Dossier

3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

· Vion Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone, covering 2013-07-18 to 2013-07-18. Get the full timeline:

Most recent: Clinical Trial Update: 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors [Phase 1]

See pricing